Search:

China Landscape Reports

With those extensive experience of industry practices in different life science areas, Loudon China keeps attention on the latest topics within the industry, and provides unique perspectives for stakeholders through its newly developed Landscape Reports on medicines, medical device, health foods and other life science areas.

All relevant stakeholders, include (but not limited) CEOs, sales & marketing VPs, R & D, BD/Marketing/Medical Directors, Researchers, Financial Analysts in pharmaceutical, medical device, health food, cosmetics, private and institutional investors in life science industry, etc.

Reports Available for Subscription

Regulatory Affairs
1. China Regulatory Affairs: Imported Health Food Key stakeholders, SFDA requirements, timeline & costs	More information
2. China Regulatory Affairs: Imported Cosmetic Key stakeholders, value chain analysis, SFDA requirements, timeline & costs	More information
3. China Regulatory Affairs: Imported Medical Device Key stakeholders, value chain analysis, SFDA requirements, timeline & costs	More information
4. China Regulatory Affairs: Imported Drug Key stakeholders,value chain analysis, SFDA requirements, timeline & costs	More information
Disease Management
1. China Rare Disease Opportunities: Gaucher Disease Epidemiology, diagnosis & treatments, product opportunities & market projection 2012-2022	More information
2. China Rare Disease Opportunities: Thalassemia Major - Epidemiology, diagnosis & treatments, product opportunities& market projection 2012-2021	More information
3. China Rare Disease Opportunities:CAPS (Cryopyrin相关周期性综合征) Epidemiology,diagnosis & treatments, product opportunities & market projection 2012-2022	More information
4. China Rare Disease Opportunities: HAE (遗传性血管性水肿) Epidemiology, diagnosis & treatments, product opportunities & market 2012-2022	More information
5. China Rare Disease Opportunities: NAGS Deficiency (乙酰谷氨酸合成酶缺乏症) Epidemiology, diagnosis & treatments, product opportunities &market 2012-2022	More information
6. China Breast Cancer Diagnosis Market 2013-2023: Unmet Needs & Opportunities	More information
7. China Lung Cancer Diagnosis Market 2013-2023: Unmet Needs & Opportunities	More information
8. China HFMD Diagnostics & Vaccines Market	More information
BD Opportunities & Industry
1. China Iron Deficiency Products Market	More information
2. China License-In/Co-Dev. Opportunities (2011 FDA-approved Products)	More information
3. China Gene Chip Market	More information
4. License-In/Co-Dev. Opportunities (2012 FDA-approved Products)	More information
5. License-In/Co-Dev. Opportunities (Till June 2013 FDA-approved Products)	More information